Health outcomes & conditions

GLP-1s With Other Health Conditions & Special Populations

Clinical trials enroll carefully selected patients; real people arrive with other diagnoses. This cluster collects the articles on GLP-1 therapy in the context of other health conditions — from rheumatoid arthritis, asthma, and migraine to eye disease, joint pain, and weight-related skin conditions — and in specific groups such as adolescents, older adults, athletes, and shift workers.

84 research articles · newest update October 2026

Recently updated

Can Your Genes Predict Weight Loss on Ozempic or Zepbound? The GLP-1 Genetics Evidence

A 2026 Nature study found a gene variant clearly linked to GLP-1 weight loss, worth about 0.76 kg per copy, plus genes tied to nausea. Why a DNA test can't yet tell you whether Ozempic or Zepbound will work, and what predicts response better.

7 min read · Updated October 2026

Does Ozempic Cause Macular Degeneration? GLP-1 Drugs and AMD Risk Evidence

A 2025 study linked semaglutide and other GLP-1 drugs to wet macular degeneration, but larger 2026 studies, including one of 5.6 million patients with diabetes, found no increased risk and some found less dry AMD. What each study showed and what it means for your eyes.

8 min read · Updated October 2026

GLP-1 Drugs for Children Under 12: Trial Results, Prescribing Trends and FDA Limits

No GLP-1 drug is FDA-approved for weight loss in children under 12, but a 56-week trial found liraglutide lowered BMI in 6- to 11-year-olds and prescribing is rising. What parents should know about the evidence, side effects, label limits and open questions.

8 min read · Updated October 2026

Cellulitis, Obesity and Lymphedema: Risk Factors, Recurrence and What Prevents It

Cellulitis symptoms and why it keeps coming back. Evidence on obesity and lymphedema as leading risk factors for leg cellulitis, how compression and preventive antibiotics cut recurrence, what weight loss can and cannot change, and the limited GLP-1 data.

11 min read · Updated October 2026

All 84 articles in this topic

Most recently updated first.

  1. Can Your Genes Predict Weight Loss on Ozempic or Zepbound? The GLP-1 Genetics Evidence7 min · October 2026
  2. Does Ozempic Cause Macular Degeneration? GLP-1 Drugs and AMD Risk Evidence8 min · October 2026
  3. GLP-1 Drugs for Children Under 12: Trial Results, Prescribing Trends and FDA Limits8 min · October 2026
  4. Cellulitis, Obesity and Lymphedema: Risk Factors, Recurrence and What Prevents It11 min · October 2026
  5. DVT and Blood Clots with Obesity: Estrogen, Surgery and What GLP-1 Data Show11 min · October 2026
  6. Lichen Sclerosus and Weight: Symptoms, Treatment, Obesity Links and Cancer Risk11 min · October 2026
  7. Meniscus Tears and Weight: Symptoms, Knee Load, Surgery vs Therapy Evidence11 min · October 2026
  8. Degenerative Disc Disease and Body Weight: What MRI Studies Show10 min · October 2026
  9. Diastasis Recti and Body Weight: Does Losing Weight Close the Gap?10 min · October 2026
  10. Dupuytren's Contracture, Diabetes and Weight: What the Evidence Shows10 min · October 2026
  11. Heat Rash (Miliaria) and Body Weight: Causes, Skin Folds and Treatment Evidence9 min · October 2026
  12. Intertrigo and Skin Fold Rash: What Changes as Weight Comes Off9 min · October 2026
  13. Knee Bursitis and Body Weight: Pes Anserine Bursitis, Diabetes and the Evidence10 min · October 2026
  14. Lipedema: Symptoms, Stages, Causes and Whether GLP-1s Help14 min · October 2026
  15. Low Back Pain, Sciatica and Body Weight: What the Evidence Shows13 min · October 2026
  16. Rotator Cuff Tears, Weight and Diabetes: Symptoms, Repair Risks and Evidence11 min · October 2026
  17. Trigger Finger and Diabetes: Blood Sugar, Weight, Treatment and GLP-1 Evidence10 min · October 2026
  18. Xanthelasma, Cholesterol and Weight: What the Eyelid Deposits Signal10 min · October 2026
  19. Frozen Shoulder and Diabetes: Risk, Weight and GLP-1 Evidence10 min · October 2026
  20. Hernia and Weight: Can a Hernia Cause Weight Gain, and What BMI Do Surgeons Want?10 min · October 2026
  21. Hip Bursitis and Body Weight: What the Evidence Shows10 min · October 2026
  22. Meralgia Paresthetica and Body Weight: Causes, Treatment and Evidence10 min · October 2026
  23. Pilonidal Cyst and Body Weight: What the Evidence Shows9 min · October 2026
  24. BMI Cutoffs for Knee and Hip Replacement: Complications, Weight Loss and GLP-1s10 min · September 2026
  25. Does Losing Weight Stop Snoring? What the Evidence Shows9 min · September 2026
  26. Lymphedema and Weight Loss: What the Evidence Shows9 min · September 2026
  27. Skin Tags, Acanthosis Nigricans and Insulin Resistance: What the Evidence Shows9 min · September 2026
  28. Carpal Tunnel Syndrome and Body Weight: What the Evidence Shows8 min · September 2026
  29. GLP-1 Drugs and the DOT Physical: What Commercial Drivers Need8 min · September 2026
  30. Plantar Heel Pain and Body Weight: What the Evidence Shows7 min · September 2026
  31. Varicose Veins, Venous Insufficiency and Weight: The Evidence7 min · September 2026
  32. Does Anemia Cause Weight Loss or Gain? Evidence Review (B12, Iron, Chronic Disease)13 min · August 2026
  33. GLP-1 + Allergy Immunotherapy and Antihistamines11 min · August 2026
  34. GLP-1 + Osteoporosis: DEXA + Bisphosphonate Stacking Evidence11 min · August 2026
  35. GLP-1 After Hepatitis C Cure (SVR): Metabolic Syndrome Reversal11 min · August 2026
  36. GLP-1 and Bone: Turnover and Density (2026)11 min · August 2026
  37. GLP-1 and BPH: Tamsulosin, Finasteride, and Urinary Symptom Evidence11 min · August 2026
  38. GLP-1 and Dental Health: Periodontitis, Xerostomia, and Procedures11 min · August 2026
  39. GLP-1 and Glaucoma: NAION Signal, IOP, and Dry Eye Evidence11 min · August 2026
  40. GLP-1 and Gout: Uric Acid, Flares, and Allopurinol Stacking Evidence11 min · August 2026
  41. GLP-1 and Hashimoto's: TPO Antibodies, Weight Loss, and Levothyroxine11 min · August 2026
  42. GLP-1 and Iron Deficiency: Ferritin, Anemia, Hair Loss Connection11 min · August 2026
  43. GLP-1 and Kidney Stones: Urolithiasis Risk and Citrate Prevention Evidence11 min · August 2026
  44. GLP-1 and Pelvic Floor: Stress Incontinence, Prolapse, and PT Evidence11 min · August 2026
  45. GLP-1 and Recurrent UTIs: Cranberry, Macrobid, and Hydration Evidence11 min · August 2026
  46. GLP-1 and Restless Legs Syndrome: Iron, Dopamine, and Mirapex Evidence11 min · August 2026
  47. GLP-1 and Wound Healing: The Evidence (2026)12 min · August 2026
  48. GLP-1 During Active Chemotherapy: What the Evidence Shows11 min · August 2026
  49. GLP-1 for Asthma and COPD: The Lung Function Evidence11 min · August 2026
  50. GLP-1 for Breast Cancer Survivors on Tamoxifen / Letrozole11 min · August 2026
  51. GLP-1 for Diabetic Foot Ulcers: Wound Healing, Offloading, and Charcot Evidence11 min · August 2026
  52. GLP-1 for Fibromyalgia and Chronic Pain: Anti-Inflammatory Evidence11 min · August 2026
  53. GLP-1 for Hidradenitis Suppurativa: Weight Loss + Humira/Cosentyx Stacking11 min · August 2026
  54. GLP-1 for HIV Patients: ART-Related Weight Gain on Integrase Inhibitors11 min · August 2026
  55. GLP-1 for Hypothalamic Obesity After Craniopharyngioma11 min · August 2026
  56. GLP-1 for IIH (Pseudotumor Cerebri): Mitchell Exenatide RCT + Weight Loss11 min · August 2026
  57. GLP-1 for Knee Osteoarthritis: STEP-9 Evidence + Surgery Bridge11 min · August 2026
  58. GLP-1 for Long COVID: Inflammation, Fatigue, and Weight Recovery Evidence11 min · August 2026
  59. GLP-1 for Patients Over 65: Sarcopenia Risk and Evidence12 min · August 2026
  60. GLP-1 for Spinal Cord Injury Patients: Mobility-Limited Obesity11 min · August 2026
  61. GLP-1 for Teens 12-17: The Pediatric Evidence12 min · August 2026
  62. GLP-1 in Acromegaly and Cushing's: Pituitary Disease Considerations11 min · August 2026
  63. GLP-1 in CF Modulator Era: New Obesity Considerations11 min · August 2026
  64. GLP-1 in Chronic Rhinosinusitis and Nasal Polyps: Dupixent Stacking Evidence11 min · August 2026
  65. GLP-1 in Chronic Urticaria: Xolair, Antihistamines, and Hives Evidence11 min · August 2026
  66. GLP-1 in Interstitial Cystitis (IC/BPS): Diet, Elmiron, and Pelvic Floor Evidence11 min · August 2026
  67. GLP-1 in Lupus and Rheumatoid Arthritis: Steroid Sparing Evidence11 min · August 2026
  68. GLP-1 in Multiple Sclerosis: DMT Stacking and Obesity Risk Evidence11 min · August 2026
  69. GLP-1 in Organ Transplant Recipients: Evidence (2026)12 min · August 2026
  70. GLP-1 in Psoriasis and Eczema: TNF-Inhibitor and Dupixent Stacking11 min · August 2026
  71. GLP-1 in Sickle Cell Disease: Safety + Obesity Considerations11 min · August 2026
  72. GLP-1 in Sjogren's Syndrome: Dry Eye, Dry Mouth, and HCQ Stacking11 min · August 2026
  73. GLP-1 With Keppra, Lamictal, and Other Antiseizure Medications11 min · August 2026
  74. GLP-1 With POTS and Dysautonomia: Heart Rate, Salt, and Midodrine Evidence11 min · August 2026
  75. GLP-1s and Bone Density: Fracture Risk Evidence Review13 min · August 2026
  76. GLP-1s for College Students: Campus Life Guide9 min · August 2026
  77. GLP-1s for Shift Workers and Night Shift8 min · August 2026
  78. Sarcopenic Obesity and GLP-1 Drugs: Protecting Muscle While Losing Fat9 min · August 2026
  79. Tattoos on a GLP-1: Healing and Timing (2026)9 min · August 2026
  80. Why Does Cancer Cause Weight Loss? Honest Evidence Review11 min · August 2026
  81. Ozempic for Psoriasis & Eczema: Emerging Anti-Inflammatory Evidence Review11 min · July 2026
  82. GLP-1 for Cancer Survivors: Patient Action Plan and Evidence Review14 min · July 2026
  83. Can Athletes Take GLP-1? Wegovy, Running, and the Honest Evidence14 min · July 2026
  84. GLP-1s with Rheumatoid Arthritis or Lupus: Honest Evidence Review13 min · July 2026